These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30487139)

  • 21. Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
    Rein DT; Volkmer A; Bauerschmitz G; Beyer IM; Janni W; Fleisch MC; Welter AK; Bauerschlag D; Schöndorf T; Breidenbach M
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):603-10. PubMed ID: 22209976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
    Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.
    Wei F; Wang H; Chen X; Li C; Huang Q
    Cancer Biol Ther; 2014 Oct; 15(10):1358-66. PubMed ID: 25019940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.
    Nettelbeck DM
    J Mol Med (Berl); 2008 Apr; 86(4):363-77. PubMed ID: 18214411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses.
    Strauss R; Sova P; Liu Y; Li ZY; Tuve S; Pritchard D; Brinkkoetter P; Möller T; Wildner O; Pesonen S; Hemminki A; Urban N; Drescher C; Lieber A
    Cancer Res; 2009 Jun; 69(12):5115-25. PubMed ID: 19491256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver.
    Ylösmäki E; Lavilla-Alonso S; Jäämaa S; Vähä-Koskela M; af Hällström T; Hemminki A; Arola J; Mäkisalo H; Saksela K
    PLoS One; 2013; 8(1):e54506. PubMed ID: 23349911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.
    Carette JE; Graat HC; Schagen FH; Abou El Hassan MA; Gerritsen WR; van Beusechem VW
    J Gene Med; 2005 Aug; 7(8):1053-62. PubMed ID: 15756711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies.
    Hamada K; Takagi S; Kuboshima H; Shimada H; Takagi K; Yasuoka T; Matsubara K; Sassa Y; Furuya T; Suzuki K; Uchide T; Mizutani T; Tani K; Itoh H; Sugiyama T
    J Gene Med; 2019 Feb; 21(2-3):e3064. PubMed ID: 30548997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptor.
    Kuryk L; Møller AW
    J Med Virol; 2020 Aug; 92(8):1309-1315. PubMed ID: 31944306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.
    Connell CM; Shibata A; Tookman LA; Archibald KM; Flak MB; Pirlo KJ; Lockley M; Wheatley SP; McNeish IA
    J Clin Invest; 2011 Apr; 121(4):1283-97. PubMed ID: 21383502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species D Adenoviruses as Oncolytic Viral Vectors.
    Bullard BL; Corder BN; Weaver EA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers.
    Du T; Shi G; Li YM; Zhang JF; Tian HW; Wei YQ; Deng H; Yu DC
    Cancer Gene Ther; 2014 Aug; 21(8):340-8. PubMed ID: 25034886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer.
    Kloos A; Woller N; Gürlevik E; Ureche CI; Niemann J; Armbrecht N; Martin NT; Geffers R; Manns MP; Gerardy-Schahn R; Kühnel F
    Cancer Immunol Res; 2015 Jul; 3(7):751-63. PubMed ID: 25701327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.
    Rojas JJ; Guedan S; Searle PF; Martinez-Quintanilla J; Gil-Hoyos R; Alcayaga-Miranda F; Cascallo M; Alemany R
    Mol Ther; 2010 Nov; 18(11):1960-71. PubMed ID: 20808288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing.
    Abate-Daga D; Andreu N; Camacho-Sánchez J; Alemany R; Herance R; Millán O; Fillat C
    PLoS One; 2011; 6(10):e26142. PubMed ID: 22028820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinia virus requires glutamine but not glucose for efficient replication.
    Fontaine KA; Camarda R; Lagunoff M
    J Virol; 2014 Apr; 88(8):4366-74. PubMed ID: 24501408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.